1. Home
  2. TONX vs HURA Comparison

TONX vs HURA Comparison

Compare TONX & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TON Strategy Company

TONX

TON Strategy Company

N/A

Current Price

$3.22

Market Cap

147.6M

ML Signal

N/A

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

N/A

Current Price

$1.40

Market Cap

123.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TONX
HURA
Founded
N/A
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
147.6M
123.0M
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
TONX
HURA
Price
$3.22
$1.40
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.04
AVG Volume (30 Days)
258.1K
★ 461.7K
Earning Date
11-10-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 69.21
47.93
EPS
N/A
★ N/A
Revenue
★ $32,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 433.33
N/A
52 Week Low
$1.75
$0.41
52 Week High
$4.44
$3.43

Technical Indicators

Market Signals
Indicator
TONX
HURA
Relative Strength Index (RSI) 50.91 32.18
Support Level $3.15 $1.27
Resistance Level $3.60 $1.55
Average True Range (ATR) 0.33 0.16
MACD 0.07 -0.04
Stochastic Oscillator 45.51 5.26

Price Performance

Historical Comparison
TONX
HURA

About TONX TON Strategy Company

TON Strategy Co is a digital asset treasury and Web3 ecosystem company focused on supporting The Open Network, a public blockchain integrated with Telegram and designed for fast, scalable transactions and decentralized applications. Its core business is managing its holdings of Toncoin (TON), including staking tokens to support network validation and earn rewards, while adhering to regulatory, accounting, and risk management standards. The company also pursues Web3 initiatives to support the ecosystem's growth and adoption. It operates through MARKET. live, Go Fund Yourself, and TON segments, with MARKET.live generating maximum revenue as a multi-vendor livestream shopping platform that combines e-commerce and entertainment across social and video channels.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Share on Social Networks: